Project Details
Description
Livio Pellizzoni, associate professor at Columbia University Medical Center in New York, was awarded an MDA research grant totaling $200,000 over two years to elucidate the underlying mechanisms of spinal muscular atrophy (SMA). Although several strategies to restore SMN levels have shown promising results in preclinical studies and are currently being tested in clinical trials, it remains essential to understand the still elusive mechanisms by which low SMN causes SMA and to define other therapeutic targets that can be pursued in parallel to SMN-enhancing approaches. To address these issues, Pellizzoni will determine whether disruption of a novel function of SMN in RNA regulation contributes to SMA pathology in a well-established mouse model that recapitulates many features of the human disorder. This work has the potential to identify new research avenues for the development of therapeutic approaches that could complement current strategies for upregulation of SMN.
Status | Finished |
---|---|
Effective start/end date | 2/1/16 → 1/31/18 |
Funding
- Muscular Dystrophy Association: US$200,000.00
ASJC Scopus Subject Areas
- Medicine(all)
- Cell Biology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.